SIGIRR Inhibits Periodontitis‐Associated Inflammation and Promotes Regeneration by Blocking Sp1 Nuclear Translocation
Journal of Periodontal Research · 2026
DOI: 10.1111/jre.70074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Periodontal Research, 2026. Verfasst von Xuanxuan Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Oral and Maxillofacial System Disease, School of Stomatology, the Third Affiliated Hospital, Xi'an Medical University,…. Hauptthemen laut MEDLINE: Periodontitis, Sp1 Transcription Factor, Receptors, Interleukin-1, Regeneration. Die Arbeit nennt 39 Literaturangaben. Gefördert von: the National Clinical Medical Research Center for Oral Diseases 2020 Special Project.
Abstract (Originalsprache)
Aim
To investigate the contribution of the Single Immunoglobulin Interleukin‐1 Receptor‐Related Molecule (SIGIRR), a recently described negative mediator of inflammation signaling, in experimental periodontitis pathogenesis.
Methods
A comprehensive approach was employed, including the analysis of human periodontal tissues, in vitro experiments with Periodontal ligament stem cells (PDLSCs), and validation in a rat experimental periodontitis model. The mechanistic link between LPS stimulation and SIGIRR downregulation was investigated, focusing on the p38 pathway and transcription factor Sp1. Functional effects of SIGIRR overexpression on inflammatory cytokine production were assessed.
Results
SIGIRR expression was markedly downregulated in periodontitis and LPS‐stimulated PDLSCs. This downregulation was mechanistically linked to LPS activation of the p38 pathway, which impaired nuclear translocation of the transcription factor Sp1, a key positive regulator of SIGIRR transcription. SIGIRR overexpression in PDLSCs significantly attenuated LPS‐induced production of pro‐inflammatory cytokines (IL‐6, IL‐8, TNF‐α). Local administration of a SIGIRR‐overexpressing lentivirus in the rat experimental periodontitis model effectively reduced local pro‐inflammatory cytokine levels, and promoted alveolar bone repair.
Conclusion
Together, our findings establish a unique role for p38‐Sp1‐SIGIRR axis in the pathogenesis of experimental periodontitis and provide evidence that SIGIRR gene therapy promises to offer an alternative option for inflammation blockade and bone repair, facilitating the development of a novel therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center of Oral and Maxillofacial System Disease, School of Stomatology, the Third Affiliated Hospital, Xi'an Medical University, Xi'an, China.
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, the Second Medical Center, School of…
ORCID-Profile: Xuanxuan Yang, Kaijin Hu
Förderung
- the National Clinical Medical Research Center for Oral Diseases 2020 Special Project
Zitieren
APA
Yang, X., Li, W., Jin, L., Li, Z., Zhang, B., Hu, K., & Cao, M. (2026). SIGIRR Inhibits Periodontitis‐Associated Inflammation and Promotes Regeneration by Blocking Sp1 Nuclear Translocation. Journal of Periodontal Research. https://doi.org/10.1111/jre.70074
Vancouver
Yang X, Li W, Jin L, Li Z, Zhang B, Hu K, et al. SIGIRR Inhibits Periodontitis‐Associated Inflammation and Promotes Regeneration by Blocking Sp1 Nuclear Translocation. Journal of Periodontal Research. 2026. doi:10.1111/jre.70074
BibTeX
@article{Yang2026,
author = {Yang, Xuanxuan and Li, Weixu and Jin, Lizi and Li, Zhixiang and Zhang, Bolun and Hu, Kaijin and Cao, Meng},
title = {SIGIRR Inhibits Periodontitis‐Associated Inflammation and Promotes Regeneration by Blocking Sp1 Nuclear Translocation},
journal = {Journal of Periodontal Research},
year = {2026},
doi = {10.1111/jre.70074}
}
EUVIMED